UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of April 2026 (Report No. 7)
Commission File Number: 001-40303
Inspira Technologies
Oxy B.H.N. Ltd.
(Translation of registrant’s name into
English)
2 Ha-Tidhar St.
Ra’anana 4366504, Israel
(Address of principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F:
☒ Form 20-F ☐ Form
40-F
CONTENTS
On April 16, 2026, Inspira Technologies Oxy B.H.N.
Ltd. (the “Company”) issued a press release titled “Inspira Completes Commercial Deployment of its AME System at a U.S.
Based Defense Entity,” a copy of which is furnished as Exhibit 99.1 with this Report of Foreign Private Issuer on Form 6-K (this
“Report”).
The first, second, third and
fifth paragraphs, as well as the section titled “Forward-Looking Statement Disclaimer,” of the press release are incorporated by
reference into the Company’s Registration Statements on Form F-3 (Registration Nos. 333-284308
and 333-289324) and Form S-8
(Registration Nos. 333-259057,
333-277980, 333-285565,
333-290162 and 333-292592),
filed with the Securities and Exchange Commission, to be a part thereof from the date on which this Report is submitted, to the extent
not superseded by documents or reports subsequently filed or furnished.
| Exhibit No. |
|
|
| 99.1 |
|
Press Release issued by Inspira Technologies Oxy B.H.N. Ltd. on April 16, 2026, titled “Inspira Completes Commercial Deployment of its AME System at a U.S. Based Defense Entity.” |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
| |
Inspira Technologies Oxy B.H.N. Ltd. |
| |
|
|
| Date: April 16, 2026 |
By: |
/s/ Dagi Ben-Noon |
| |
|
Name: |
Dagi Ben-Noon |
| |
|
Title: |
Chief Executive Officer |
2
Exhibit 99.1

Inspira Completes Commercial Deployment of its
AME System at a Tier-1 U.S. Defense Entity
RA’ANANA, Israel, April 16,
2026 — Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (“Inspira” or the “Company”), today announced
the successful delivery and acceptance of an Additively Manufactured Electronics (“AME”) system at a Tier-1 U.S. defense customer
site under a commercial agreement.
The customer site operates within a broader ecosystem of strategic
defense initiatives, including quantum computing, quantum networking, integrated photonics, and superconducting systems. Advancing these
sophisticated fields requires overcoming critical hardware bottlenecks, particularly regarding complex component integration and extreme
miniaturization.
Inspira’s AME platform is purposefully built for these constraints,
enabling the rapid fabrication of highly integrated electronic structures with ultra-compact architectures and geometries that are difficult
or impossible to achieve through standard processes. The engagement includes ongoing supply of proprietary consumables and materials,
establishing a contractual foundation for recurring revenue beyond the initial system sale, with additional revenue potential from application-specific
adaptations as the customer’s usage scales.
“We view this deployment as a representation of the tangible
commercial execution of our AME strategy in an advanced customer environment,” said Dagi Ben-Noon, Chief Executive Officer of Inspira.
“This milestone confirms the commercial demand for our AME platform in top-tier defense operations and may serve as a powerful catalyst
for our accelerating financial momentum and growth.”
The customer’s identity and specific transaction terms are not being
disclosed, in accordance with confidentiality requirements which are customary for engagements with U.S. defense entities of this profile.
About Inspira Technologies
Inspira Technologies OXY B.H.N. Ltd.
(Nasdaq: IINN, IINNW) is a technology company focused on solving the most critical physical and hardware bottlenecks in quantum computing
connectivity. Inspira develops unique quantum connectivity solutions designed for high-density, thermally optimized operation in dilution
cryostats, a prerequisite for scaling quantum systems beyond current physical limitations. Additionally, the Company continues to advance
its medical technology portfolio, including its respiratory support and blood monitoring platforms under a dedicated business unit. For
more information, please visit: www.q-trex.com and www.inspira-technologies.com
Forward-Looking Statement Disclaimer
This press release contains
express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements are based on
the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause
actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking
statements when it discusses its AME platform’s ability to overcome constraints and enable rapid fabrication of highly integrated
electronic structures with ultra-compact architectures and geometries; its ability to supply proprietary consumables and materials as
part of the engagement; its ability to establishing a contractual foundation for recurring revenue beyond the initial system sale; the
additional revenue potential from application-specific adaptations as the customer’s usage scales; and that the milestone confirms
the commercial demand for its AME platform in top-tier defense operations and serves as a powerful catalyst for its accelerating financial
momentum and growth. These forward-looking statements and their implications are based solely on the current expectations of the Company’s
management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described
in the forward-looking statements. Except as otherwise required by law, the Company undertakes no obligation to publicly release any
revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of
unanticipated events. More detailed information about the risks and uncertainties affecting the Company is contained under the heading
“Risk Factors” in the Company’s annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with
the U.S. Securities and Exchange Commission (the “SEC”), which is available on the SEC’s website at www.sec.gov.
Company Contact
Inspira Technologies
Email: info@inspirao2.com
Phone: +972-9-9664485
Investor Relations Contact
Arx Investor Relations
North American Equities Desk
inspira@arxhq.com